US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

MindWalk Holdings Corp

us-stock
To Invest in {{usstockname}}
us-stock
$1.9577 -0.035(-3.5%) HYFT at 09 Dec 2025 05:46 PM Biotechnology
Lowest Today 1.935
Highest Today 1.9986
Today’s Open 1.97
Prev. Close 2
52 Week High 3.25
52 Week Low 0.27
Day’s Range: Low 1.935 High 1.9986
52-Week Range: Low 0.27 High 3.25
1 day return -
1 Week return +11.42
1 month return +9.55
3 month return +2.63
6 month return -18.06
1 year return -
3 year return -
5 year return -
10 year return -

Institutional Holdings

Market Status

Fundamentals

Market Cap 81.69 M

PB Ratio 5.4604

PE Ratio 0.0

Enterprise Value 59.97 M

Total Assets 44.44 M

Volume 154656

Company Financials

Annual Revenue FY25:24520000 24.5M

Annual Profit FY25:13548000 13.5M

Annual Net worth FY25:-30234000 -30.2M

Quarterly Revenue Q3/2025:3161000 3.2M, Q2/2025:6981000 7.0M, Q1/2025:6151000 6.2M

Quarterly Profit Q3/2025:1527000 1.5M, Q2/2025:4460000 4.5M, Q1/2025:3295000 3.3M

Quarterly Net worth Q3/2025:-2959000 -3.0M, Q2/2025:-2161000 -2.2M, Q1/2025:-21521000 -21.5M

Fund house & investment objective

Company Information MindWalk Holdings Corp. operates as a bio-native AI company. It focuses on the integration of artificial intelligence, multi-omics data, and advanced laboratory research to accelerate the discovery and development of biologics. The company, through its LensAI platform and HYFT technology, it partners with pharmaceutical and biotechnology companies to drive de-risk drug development and unlock therapeutic possibilities. The company was formerly known as ImmunoPrecise Antibodies Ltd. and changed its name to MindWalk Holdings Corp. in September 2025. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Organisation Biotechnology

Employees 81

Industry Biotechnology

CEO Dr. Jennifer Lynne Bath Ph.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right